SMXT Q1 2026 Earnings Narrow Loss Highlights Cost Management Focus Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech Veris Residential Inc Q4 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress Mannatech Q3 2023 Earnings Modest Profitability Amid Limited Disclosures CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment